Patent offices come under lens
Public interest groups and health advocacy firms have raised doubts over the validity of several medicine patents that have been granted by Indian patent offices in recent times. The medicines include tuberculosis (TB) drug moxifloxacin, antipsychotic olanzapine and valgancicloivir, a medicine often needed for HIV / AIDS patients.